DOCSLIB.ORG

Health Services Preparedness for Pandemic Influenza. Facilitator's

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Health Services Preparedness for Pandemic Influenza. Facilitator's Facilitator’s Manual FOREWORD The emergence of an avian influenza strain capable of infecting humans has served as a strong reminder of humankind’s vulnerability to another pandemic. Successful control and containment of a pandemic will be dependent on early recognition of the first instances of human-to-human transmission with timely detection and rapid response. Timely detection will only be accomplished by increasing the sensitivity of surveillance systems at all levels. One strategy for reaching such an increase is the involvement and training of healthcare workers to engage their efforts in the notification of signal events that may indicate the emergence of a new pathogen with pandemic potential. This training package aims at providing such training and at offering tools to facilitate the response by healthcare facilities in a situation where the demand for services surpasses their operating capacity. This training package draws upon the growing body of knowledge on influenza, and attempts to consolidate it in an easy-to-use format for healthcare workers. The materials included in this training package have been designed as a generic guideline that requires adaptation to country specificities. Of particular importance is the inclusion of country- specific procedures for the immediate notification of such signal events. While this material has been developed with influenza in mind, the capacities that will be reinforced by the tools provided in this training package will serve for the detection, notification, and response to any disease with epidemic potential. The strengthening of such basic public health capacities will be fundamental in the implementation of the new International Health Regulations. It is hoped that this material will be of assistance to national programs tasked with the challenging but necessary task of preparing for a possible influenza pandemic. Health Surveillance, Health Systems and Services Area (HSS) Disease Prevention and Control Area (HSD) Pan American Health Organization ~Agenda coordination meeting ~Summary of the course ~Participants Profile ~Pre/Pos test ~Course evaluation COORDINATION MEETING We propose the holding of a preliminary meeting with national counterparts to go over the materials and review the presentations. The presentation review will be of particular importance when the presentations will be given by national counterparts. This time will be an opportunity to adapt the material to national specificities. The coordination meeting is also an opportunity to define who will be taking over the practical demonstrations and who will be the national facilitators for the case studies at the end of each day of the course. It is of the utmost importance that, if available, the following professionals from the ministry of health participate in this coordination meeting: the person(s) charged with respiratory disease surveillance, the person(s) charged with health services delivery; the person(s) charged with laboratory diagnosis of influenza; the person(s) coordinating communications in the pandemic preparedness process; and the person or commission charged with infection control. The following topics should be discussed: 1. General introduction of the strategy 1.1. Implementation of the Nationwide enhanced surveillance 1.2. Preparation of health services 1.3. Implementation of the International Health Regulations 2. Sub-national replication of the course 3. Suggested profile of the participants 4. Definition of next steps 5. Presentation of the course agenda 6. Definition of facilitators for case studies 7. Review of the presentations that will be delivered by national counterparts: 7.1. National Influenza Pandemic Preparedness Plan 7.2. Information flows of the national surveillance system 7.3. Laboratory 7.3.1. Laboratory tests 7.3.2. Sample taking and shipment 7.3.3. Practical demonstration of sample taking 7.4. Infection Control 7.4.1. ABC 7.4.2. Specific precautions for SARI 7.5. Communication 7.5.1. Risk Communication 7.5.2. National communications strategy for a pandemic Summary of the course for Health Establishments Preparedness for Clusters or Unusual or Unexpected Cases of SARI Purpose of the course To strengthen the capacity of the health facilities to detect and to respond rapidly to one or more cases of unusual or unexpected severe acute respiratory infection (SARI), including those caused by human influenza. General Objetive Part I - Prepare healthcare workers for detection and early management of a unusual case or cluster of SARI within healthcare facilities thus enabling the early identification of emerging agents and their investigation and control on a timely manner.. Part II – Provide tools for improvement of the response by healthcare facilities in a situation of SARI cases that exceed their capacity in order to achieve adequate and efficient care. Methodology: The content of the training package is based on the Generic Protocol for Influenza Surveillance developed by PAHO and Centers for Disease Prevention and Control of the United States (CDC) (4), on WHO guidelines, and on scientific articles from peer-reviewed journals. The packed was designed for a training course for a group 40 people. The course consists of short presentations from 20 to 30 minutes, followed by a discussion of each topic. The material presented will be supplemented with exercises, case studies, practical demonstrations, and simulations where participants will be separated into smaller work groups of 5 to 8 people. It is important to emphasize that the course is aimed at healthcare workers whose work include the inpatient treatment of patients with SARI. Profile of participants: This course is meant for healthcare workers, particularly those at healthcare facilities where patients are admitted. This includes all healthcare workers that treat patients, such as nurses, physicians, laboratory personnel, etc. The course also contains components directed to the management and coordination of health services, so the course should involve medical coordinators and managers. As the first course is meant to train future trainers, it is essential to have the participation of those charged with surveillance at the national and sub-national level, as well as those responsible for rapid response teams for the field investigation of possible outbreaks. We include a proposal for a breakdown of the participants’ profiles by categories for the first, train-the-trainers course. PART I ‐ Detection and Management of SARI Objetives: That healthcare workers in every facility be capable of detecting on a timely basis: 9 Unusual or unexpected SARI cases; 9 Clusters of SARI 9 Excess cases of SARI. That healthcare workers in every facility be capable of responding on a timely basis to: 9 Carry out effective case management while observing infection control standards 9 Report such events immediately to corresponding sub-national and/or national authorities for the mobilization of rapid response teams according to the mechanisms established in the country. 9 Collect adequate samples from these cases and appropriately ship them to the laboratory in a timely manner. 9 Know the International Health Regulations 2005 and their role in its implementation Time Topic 1st DAY 8:00-8:30 Registration and Opening 8:30-9:15 Pre Test with 36 questions 9:15-9:30 Introduction, objectives, and presentation of the methodology 9:30-10:15 Influenza Basics Objective: To present characteristics of the influenza virus, of seasonal influenza, avian influenza in humans, and pandemic influenza 10:15-10:30 Break 10:30-11:00 International Health Regulations (IHR-2005) Objective: To confer knowledge about the International Health Regulations and the necessary basic competencies defined there for surveillance and response. 11:00-11:30 Influenza Pandemic and Preparedness Objective: To present pillars for pandemic preparedness 11:30-12:00 National Influenza Pandemic and Preparedness Objective: To present country advances in preparing for a pandemic. This presentation should be given by the person closely involved with the pandemic preparedness process in the given country. This presentation can be consolidated with the presentation before it, for the interest of time, provided both topics are presented by national counterparts. 12:00-13:30 Lunch 13:30-14:10 Generic Protocol for Influenza Surveillance (GPIS) Objective: To familiarize participants with the basic concepts and case definitions proposed by the GPIS, including sentinel surveillance and nationwide enhanced surveillance of influenza. The presentation of the GPIS should be followed by a presentation of the routine reporting system and information flows for each country. This second presentation should be given by those responsible for the surveillance of respiratory diseases at the national level. 14:10-15:15 Nationwide Enhanced Surveillance Objective: Make healthcare workers aware of the need to notify unusual and unexpected events. Specifically, train in the early detection of SARI triggers for the notification, investigation, sampling, and management of cases. 15:15-15:30 Break 15:30-17:30 Surveillance exercises The group will be divided in three to five groups and three real events will be presented, each unexpected or unusual due to different characteristics (if more than three groups are conformed, some groups will be reviewing the same event). The groups should be moderated by national counterparts, and the discussion should include aspects of what makes the event unusual or unexpected,
Load more

Recommended publications
  • COVID-19 Infection Prevention Control Strategies For
    COVID-19 Infection Prevention Control Strategies for Massachusetts Masonic Facilities DRAFT 4/6/2020 Introduction With phrases such as “social distancing,” “self-quarantine,” and “flattening the curve” still showing up in the media, flattening the curve” still showing up in the media, blood donations have plummeted as schools, offices and other sites that typically host blood drives shut down to prevent the spread of coronavirus. As Masonic lodges across the commonwealth rise to meet the growing demand for locations, all masons must understand and be able to effectively communicate to others the importance of precautionary measures against the potential spread of CODID-19 while hosting blood drives in our buildings. Background The COVID-19 virus has actually been named "SARS-CoV-2," and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19"). The virus looks like it's wearing a spiky crown, so it gets the name "corona" from the Latin word for crown. The virus enters cells using the "spike" on its surface to enter and bond with a human cell. Once inside human cells, the virus reproduces. Those reproductions break out of cells and infect other human cells. At a certain point, there are so many virus particles being produced that our normal cells can't work properly and we get sick. Viruses are believed to be transmitted from person-to-person primarily through virus-laden droplets that are generated when infected persons speak, cough, or sneeze. These droplets can be deposited onto the mucosal surfaces of susceptible persons or hard surfaces that are within 6 feet of the droplet sourcei.
    [Show full text]
  • 'Spanish' Influenza
    1918 ‘Spanish’ Influenza: Lessons from the Past Jeffery Taubenberger, M.D., Ph.D. May 1, 2012 Influenza A virus (IAV) Family: Orthomyxoviridae •Negative sense, segmented, single-stranded RNA genome •8 segments, 12-13 ORF’s NA NA (9 NA subtypes) Nomenclature: SA ααα2-6Gal e.g., H5N1, H3N2 HA SA ααα2-3Gal (17 HA subtypes) Modified from: Horimoto & Kawaoka (2005) Nat Rev Micro 3:591-600 “Shift and Drift” Influenza A virus host range is quite diverse ? Influenza A viruses in animals Influenza A viruses in humans Annual epidemics with >200,000 hospitalizations; & up to 49,000 deaths/yr. in U.S. Occasional and unpredictable pandemic strains with increase in illness and death Pandemics are derived zoonotically: 1918, 1957, 1968, 2009 Morens, et al . 2009 NEJM . 361:225-229 The influenza problem: Influenza New strains pandemics emerge continually emerge; unpredictably and host range is very have variable extensive characteristics Human influenza A timeline H1N1 H3N2 H3N? H2N2 H1N1 H1N1 1889 1918 1957 1977 2009 1968 N = 4 Mortality impacts of past influenza pandemics Influenza pandemics throughout history • At least 14 pandemics in last 500 years (since 1510) • Average inter-pandemic interval = 36 years • Severity variable Morens & Taubenberger 2011. Rev Med Virol 21:262 1918 ‘Spanish’ influenza mortality • Total deaths in the 9 months of the pandemic in 1918-1919 estimated to be 50 million • U.S. Deaths = 675,000 • U.S. Military deaths to flu = 43,000 (out of ~100,000 U.S. Troop casualties in W.W.I.) • Case fatality rate ~1-2%; >98% had self-limited
    [Show full text]
  • Prevention and Control of Influenza During a Pandemic for All Healthcare Settings
    Annex F Prevention and Control of Influenza during a Pandemic for All Healthcare Settings Date of Latest Version: May 2011 1. E-Links have been inserted to direct the reader to the appropriate Section of the Annex. 2. This Annex has been developed for use by healthcare workers including but not limited to those working in infectious diseases, risk management, infection prevention and control, occupational health, occupational hygiene and/or emergency response. 3. The recommendations in this Annex must be interpreted by trained personnel prior to implementation in specific situations, organizations or healthcare settings. 4. A major assumption underlying this Annex was that a pandemic virus would cause severe disease in patients. - Should mild disease occur as in pH1N1, recommendations related to PPE may change. 5. As with all guidance documents related to pandemic influenza, healthcare organizations and personnel should be mindful of specifc provincial/ territorial legislation and policies that may influence or supersede the application of some of the recommendations in this Annex. 6. NOTE: This version of Annex F is being published after the pH1N1 Pandemic (H1N1). The assumptions about influenza epidemiology in this document are generalized to include all potential influenza pandemics and are not specific to pH1N1. To view the PHAC Guidance Documents related to pH1N1 go to: http:///www.phac-aspc.gc.ca/alert-alerte/h1n1/ guidance_lignesdirectrices-eng.php. These Guidance Documents have been adapted from this Annex based on emerging epidemiologic evidence and the impact of pH1N1 infection. 7. In Canada, public health is a shared responsibility of the Federal, Provincial and Territorial governments.
    [Show full text]
  • 2019 Icar Program & Abstracts Book
    Hosted by the International Society for Antiviral Research (ISAR) ND International Conference 32on Antiviral Research (ICAR) Baltimore MARYLAND PROGRAM and USA Hyatt Regency BALTIMORE ABSTRACTS May 12-15 2019 ND TABLE OF International Conference CONTENTS 32on Antiviral Research (ICAR) Daily Schedule . .3 Organization . 4 Contributors . 5 Keynotes & Networking . 6 Schedule at a Glance . 7 ISAR Awardees . 10 The 2019 Chu Family Foundation Scholarship Awardees . 15 Speaker Biographies . 17 Program Schedule . .25 Posters . 37 Abstracts . 53 Author Index . 130 PROGRAM and ABSTRACTS of the 32nd International Conference on Antiviral Research (ICAR) 2 ND DAILY International Conference SCHEDULE 32on Antiviral Research (ICAR) SUNDAY, MAY 12, 2019 › Women in Science Roundtable › Welcome and Keynote Lectures › Antonín Holý Memorial Award Lecture › Influenza Symposium › Opening Reception MONDAY, MAY 13, 2019 › Women in Science Award Lecture › Emerging Virus Symposium › Short Presentations 1 › Poster Session 1 › Retrovirus Symposium › ISAR Award of Excellence Presentation › PechaKucha Event with Introduction of First Time Attendees TUESDAY, MAY 14, 2019 › What’s New in Antiviral Research 1 › Short Presentations 2 & 3 › ISAR Award for Outstanding Contributions to the Society Presentation › Career Development Panel › William Prusoff Young Investigator Award Lecture › Medicinal Chemistry Symposium › Poster Session 2 › Networking Reception WEDNESDAY, MAY 15, 2019 › Gertrude Elion Memorial Award Lecture › What’s New in Antiviral Research 2 › Shotgun Oral
    [Show full text]
  • HHS 2009 H1N1 Influenza Improvement Plan
    U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 2009 H1N1 Influenza Improvement Plan May 29, 2012 TABLE OF CONTENTS Contents STATEMENT BY SECRETARY SEBELIUS.......................................................................... iii EXECUTIVE SUMMARY ......................................................................................................... iv CHAPTER 1: INTRODUCTION................................................................................................ 1 CHAPTER 2: DETECTION AND CHARACTERIZATION OF A FUTURE INFLUENZA PANDEMIC ................................................................................................................................... 5 CHAPTER 3: COMMUNITY MITIGATION MEASURES ................................................... 8 CHAPTER 4: MEDICAL SURGE CAPACITY ..................................................................... 12 CHAPTER 5: MEDICAL COUNTERMEASURES (MCM) FOR INFLUENZA OTHER THAN VACCINES ..................................................................................................................... 17 CHAPTER 6: VACCINE MANUFACTURING, DISTRIBUTION, AND POST- DISTRIBUTION......................................................................................................................... 25 CHAPTER 7: COMMUNICATIONS....................................................................................... 17 CHAPTER 8: CROSS-CUTTING PREPAREDNESS ISSUES............................................ 33 CHAPTER 9: INTERNATIONAL PARTNERSHIPS AND CAPACITY BUILDING ACTIVITIES
    [Show full text]
  • Non-Pharmaceutical Measures to Prevent Influenza Transmission
    September 2011 Non-Pharmaceutical Measures to Prevent Influenza Transmission: The Evidence for Individual Protective Measures Alexis Crabtree, MPH, 1 and Bonnie Henry,MD, MPH, FRCP(C)1,2 1University of British Columbia; 2British Columbia Centre for Disease Control Key Points Introduction • Mask use by cases and/or household contacts may be efficacious A wealth of knowledge has become in reducing the transmission of influenza, but that effectiveness available concerning influenza is likely reduced by poor compliance. Mask use in the community prevention and control in the wake of setting is of dubious benefit, as is the use of N95 respirators rather the 2009 H1N1 pandemic. The purpose than surgical masks outside of health care settings. of this review is to summarize the recent • Isolation and quarantine are effective and acceptable interventions literature on several non-pharmaceutical to reduce the spread of influenza, particularly pandemic influ- interventions: masks; quarantine, enza. Social distancing measures (excluding school closures and isolation, and social distancing; and prohibitions on mass gatherings, which are covered in another hand hygiene, respiratory hygiene, and paper in this series (Roth, 2011)), however, are of unproven value cleaning of fomites. and associated with low uptake. Special attention should be paid to providing tools and supports to those in quarantine or isolation, particularly to vulnerable groups. Masks A recently updated Cochrane review • Moderate evidence exists to support recommendations for hand concluded that mask use can interrupt and respiratory hygiene, especially in children. Further research is the transmission of influenza (1). While needed to show benefits from cleaning and disinfection of surfac- es in household and public spaces.
    [Show full text]
  • 2017 Update to the Hhs Pandemic Influenza Plan
    Pandemic Influenza Plan 2017 UPDATE U.S. Department of Health and Human Services Contents FOREWORD .............................................................................................................. 3 EXECUTIVE SUMMARY ........................................................................................... 5 INTRODUCTION ........................................................................................................ 7 SCOPE, AUDIENCE, AND PURPOSE ................................................................... 10 INFLUENZA RESPONSE ACTIVITIES ................................................................... 11 PLANNING TOOLS FOR PREPARATION AND RESPONSE ............................... 12 THE 2017 UPDATE TO THE HHS PANDEMIC INFLUENZA PLAN ..................... 13 Domain 1 – Surveillance, Epidemiology, and Laboratory Activities .................. 14 Domain 2 – Community Mitigation Measures .................................................... 18 Domain 3 – Medical Countermeasures: Diagnostic Devices, Vaccines, Therapeutics, and Respiratory Devices ............................................................. 21 Domain 4 – Health Care System Preparedness and Response Activities ....... 27 Domain 5 – Communications and Public Outreach ........................................... 30 Domain 6 – Scientific Infrastructure and Preparedness .................................... 32 Domain 7 – Domestic and International Response Policy, Incident Management, and Global Partnerships and Capacity Building ........................
    [Show full text]
  • Cute, Dangerous Or Both?
    [ABCDE] VOLUME 5, ISSUE 6 Cute, Dangerous or Both? ASSOCIATED PRESS Newborn chicks, at a poultry farm in Burgos, northern Spain, might someday be carriers of a disease called bird flu. INSIDE Cause Assessing the Resurrecting $1 Billion 6 for Concern 8 Bird Flu 13 1918 Flu 20 Award July 1, 2006 © 2006 THE WASHINGTON POST COMPANY VOLUME 5, ISSUE 5 An Integrated Curriculum For The Washington Post Newspaper In Education Program Endemic, Epidemic or Pandemic? Health Watch Lesson: As individuals, companies, • Seasonal (or common) flu kills www.who.int/csr/disease/influenza/ health officials and governments thousands each year. It can be pandemic/en/ confront an outbreak of mumps transmitted person to person, but Epidemic and Pandemic Alert and Response and a potential virulent spread most people have some immunity (EPR) of the avian flu, students can to it and a vaccine is available. World Health Organization provides explore public health, privacy • The influenza viruses that cause background and preparedness plans, rights and economic decisions. avian (or bird) flu occur naturally including the WHO global influenza The concerns about avian flu among wild birds. The H5N1 preparedness plan. Latest information on also provide opportunity to teach variant is deadly to domestic situation in countries around the globe. students about the Spanish Flu that fowl and can be transmitted from killed more than 50 million people birds to humans. There is no www.pandemicflu.gov/ around the world and to introduce human immunity and no vaccine PandemicFlu.gov students to careers in virology and is available. U.S. government avian and pandemic flu epidemiology.
    [Show full text]
  • NIH Public Access Author Manuscript Vaccine
    NIH Public Access Author Manuscript Vaccine. Author manuscript; available in PMC 2009 September 12. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Vaccine. 2008 September 12; 26(Suppl 4): D59±D66. doi:10.1016/j.vaccine.2008.07.025. PATHOLOGY OF HUMAN INFLUENZA REVISITED Thijs Kuikena,* and Jeffery Taubenbergerb aDepartment of Virology, Erasmus MC, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. bLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 33 North Dr, Bethesda, MD 20892-3203 USA. Summary The pathology of human influenza has been studied most intensively during the three pandemics of the last century, the last of which occurred in 1968. It is important to revisit this subject because of the recent emergence of avian H5N1 influenza in humans as well as the threat of a new pandemic. Uncomplicated human influenza virus infection causes transient tracheo-bronchitis, corresponding with predominant virus attachment to tracheal and bronchial epithelial cells. The main complication is extension of viral infection to the alveoli, often with secondary bacterial infection, resulting in severe pneumonia. Complications in extra-respiratory tissues such as encephalopathy, myocarditis, and myopathy occur occasionally. Sensitive molecular and immunological techniques allow us to investigate whether these complications are a direct result of virus infection or an indirect result of severe pneumonia. Human disease from avian influenza virus infections is most severe for subtype H5N1, but also has been reported for H7 and H9 subtypes. In contrast to human influenza viruses, avian H5N1 virus attaches predominantly to alveolar and bronchiolar epithelium, corresponding with diffuse alveolar damage as the primary lesion.
    [Show full text]
  • Better Global Tools for Influenza
    11–12 June 2019 | Geneva, Switzerland BETTER GLOBAL TOOLS FOR INFLUENZA Technical consultation on product research & innovation for influenza prevention, control & treatment Prevent. Control. Prepare. 11–12 June 2019 | Geneva, Switzerland BETTER GLOBAL TOOLS FOR INFLUENZA Technical consultation on product research & innovation for influenza prevention, control & treatment WHO/WHE/IHM/IPR/2019.1 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Better global tools for influenza. Technical consultation on product research and innovation for influenza prevention, control and treatment, Geneva, Switzerland, 11-12 June 2019.
    [Show full text]
  • Disinfecting and Sanitizing
    Volume 4, Issue 2 Disease Prevention Information for Child Care Providers December 2014 Disinfecting and Sanitizing Group care settings such as child cares, preschools, and school-age programs provide ideal conditions for spreading germs that cause illness. Caregivers use cleaning, sanitizing, and disinfecting to help reduce the Call or Email Us! number of germs in the environment. Due to some recent changes made by the bleach industry, now is a good time to review your child Main line care’s cleaning and sanitizing/disinfecting practices and make sure the 425.339.5278 products and procedures you are using are doing the job right. [email protected] What three steps are required? Public Health Nurse Alba Suárez It is important to follow all three steps in order to get rid of germs on 425.339.5228 surfaces: 1) Clean the surface with plain soap and water. [email protected] 2) Rinse the soap off the surface with plain water. Environmental Health Specialist 3) Sanitize or disinfect the surface. Micha Horn 425.339.8712 How did bleach solutions recently change? [email protected] In the past, almost all bleach that one could find on store shelves was between 5.25% and 6.0% sodium hypochlorite (the active ingredient in bleach). All the In this issue… recipes that had previously been published for child cares to make bleach Disinfecting & Sanitizing… water solutions assumed a concentration Chemical Safety…. of 5.25% to 6.0% bleach. Last year, many Bleach Chart…. bleach manufacturers started making a Disease in the News…….. “concentrated” bleach formula containing 8.25% sodium hypochlorite.
    [Show full text]
  • Research Findings from Nonpharmaceutical Intervention Studies for Pandemic Influenza And&Nbsp
    Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research Allison E. Aiello, PhD, MS,a Rebecca M. Coulborn, MPH,a Tomas J. Aragon, DrPH,b Michael G. Baker, MBChB, DPH, FAFPHM,c Barri B. Burrus, PhD,d Benjamin J. Cowling, PhD,e Alasdair Duncan, MPH,c Wayne Enanoria, PhD, MPH,b M. Patricia Fabian, ScD, MS,f,g Yu-hui Ferng, MPA,h Elaine L. Larson, PhD, RN, FAAN, CIC,h,i Gabriel M. Leung, MD, MPH, CCFP, FFPH, FHKCCM, FHKAM,e Howard Markel, MD, PhD,j Donald K. Milton, MD, DrPH,k Arnold S. Monto, MD,a Stephen S. Morse, PhD,i J. Alexander Navarro, PhD,j Sarah Y. Park, MD, FAAP,l Patricia Priest, DPhil, MBChB, MPH, FAFPHM,c Samuel Stebbins, MD, MPH,m Alexandra M. Stern, PhD,j Monica Uddin, PhD,a Scott F. Wetterhall, MD, MPH,d and Charles J. Vukotich Jr, MSm Ann Arbor, Michigan; Berkeley, California; Otago, New Zealand; Research Triangle Park, North Carolina; Hong Kong, People’s Republic of China; Lowell, Massachusetts; Boston, Massachusetts; New York, New York; College Park, Maryland; Honolulu, Hawaii; and Pittsburgh, Pennsylvania In June 2006, the Centers for Disease Control and Prevention released a request for applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical interventions (NPIs)—strategies other than vaccines and antiviral medications—to mitigate the spread of pandemic influenza within communities and across international borders (RFA-CI06-010). These studies have provided major contributions to seasonal and pandemic influenza knowledge. Nonetheless, key concerns were identified related to the accept- ability and protective efficacy of NPIs.
    [Show full text]